We are thrilled to celebrate Kindling Bio, one of our fantastic tenants at the Innovation Gateway, for being awarded 1st Prize at Hack4Hope 2025, hosted by the Paris‑Saclay Cancer Cluster (PSCC) in Paris! 🎉
Hack4Hope is an international challenge bringing together innovators, researchers, clinicians, and patient advocates to accelerate breakthroughs in childhood cancer research. Kindling Bio stood out from a competitive field of nine finalists, winning first place, prize funding, and strategic support from PSCC – a testament to their innovative work in gene therapy for paediatric cancers.
Dr. Aleck Jones, Co‑founder and CEO of Kindling Bio said “This recognition from Hack4Hope and the Paris‑Saclay Cancer Cluster is hugely meaningful for us as a young company. Engaging with clinicians, patient advocates, and experts across paediatric oncology has strengthened our thinking and sharpened our path forward.”
We’re incredibly proud to have Kindling Bio as part of our Innovation Gateway community. Their dedication, creativity, and impact-driven approach are exactly what makes our hub such an exciting place for science and innovation.
Well done, Kindling Bio! We look forward to seeing your continued success as you advance new therapies that could change the lives of children with cancer.
